Which has the lower trailing P/E, AMGN or NVO?

NVO has the lower trailing P/E: AMGN trades at 26.80 and NVO at 11.01. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AMGN or NVO?

Over the past five years, NVO grew revenue faster — AMGN at a 8.15% CAGR versus NVO at 20.73%.

Does AMGN or NVO pay a bigger dividend?

AMGN yields 2.54% and NVO yields 3.83% based on trailing dividends and the latest price.

Is AMGN or NVO more profitable?

NVO runs the higher net margin — AMGN at 20.95% versus NVO at 37.14%.

How have AMGN and NVO total returns compared?

Over the past 10 years, AMGN delivered 11.66% and NVO delivered 7.59% annualized total return. Past performance doesn't predict future results.

Amgen Inc. (AMGN) vs Novo Nordisk A/S (NVO)

A side-by-side comparison of Amgen Inc. and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 1, 2026. Differences are shown without an overall score or investment verdict.

AMGN

Amgen Inc.

$207.87B

$385.16HealthcareAt close: Jul 31, 2026, 4:00 PM ET

NVO

Novo Nordisk A/S

$209.19B

$47.08HealthcareAt close: Jul 31, 2026, 4:00 PM ET

Total return — AMGN vs NVO

growth of $100 · dividends reinvested · last 30y

AMGN +4098.1%NVO +10806.6%NVO compounded faster

AMGN NVO

AMGN vs NVO: by the numbers

•NVO is the larger company ($209.19B vs $207.87B market cap).
•NVO trades at the lower trailing earnings multiple (11.01 vs 26.80 P/E), one valuation lens rather than an overall verdict.
•NVO converts more revenue to profit (37.14% vs 20.95% net margin).
•NVO grew revenue faster over the past five years (20.73% vs 8.15% CAGR).
•NVO pays the higher dividend yield (3.83% vs 2.54%).

Metrics side by side

Valuation

Metric	AMGN	NVO
P/E ratio	26.80	11.01
Forward P/E	17.23	N/A
P/S ratio	5.63	4.09
P/B ratio	22.80	6.69
PEG ratio	0.26	8.16
EV / EBITDA	15.28	8.62
FCF yield	4.10%	2.31%

Profitability

Metric	AMGN	NVO
Gross margin	71.46%	81.83%
Operating margin	31.63%	45.21%
Net margin	20.95%	37.14%
ROE	84.87%	60.74%
ROIC	13.16%	29.53%

Dividends

Metric	AMGN	NVO
Dividend yield	2.54%	3.83%
Payout ratio	68.39%	49.80%

Growth (annualized)

Metric	AMGN	NVO
Revenue CAGR (5Y)	8.15%	20.73%
EPS CAGR (5Y)	2.94%	19.59%
FCF CAGR (5Y)	-2.66%	-5.86%
Total return CAGR (5Y)	13.29%	2.46%

Frequently asked

Which has the lower trailing P/E, AMGN or NVO?: NVO has the lower trailing P/E: AMGN trades at 26.80 and NVO at 11.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AMGN or NVO?: Over the past five years, NVO grew revenue faster — AMGN at a 8.15% CAGR versus NVO at 20.73%.
Does AMGN or NVO pay a bigger dividend?: AMGN yields 2.54% and NVO yields 3.83% based on trailing dividends and the latest price.
Is AMGN or NVO more profitable?: NVO runs the higher net margin — AMGN at 20.95% versus NVO at 37.14%.
How have AMGN and NVO total returns compared?: Over the past 10 years, AMGN delivered 11.66% and NVO delivered 7.59% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AMGN analysis Full NVO analysis Interactive comparison tool

Dig into the metrics

Amgen P/E ratio Novo Nordisk A/S P/E ratio Amgen dividend yield Novo Nordisk A/S dividend yield Amgen ROE Novo Nordisk A/S ROE Amgen operating margin Novo Nordisk A/S operating margin Amgen revenue growth Novo Nordisk A/S revenue growth Amgen free cash flow Novo Nordisk A/S free cash flow

Amgen & Novo Nordisk A/S appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 1, 2026.